Product
imlifidase
Aliases
Idefirix
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
An Open-Label, Systemic Gene Delivery Study to Evaluate the Safety, Tolerability and Expression of SRP-9001 in Association With Imlifidase in Subjects With Duchenne Muscular Dystrophy With Pre-existing Antibodies to rAAVrh74Status: Active (not recruiting), Estimated PCD: 2025-01-31